DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand five hundred one dollars and ninety cents ($30,501.90) by the Defense Logistics Agency. This order is being issued against the prime vendor's existing indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will deliver two thousand four hundred (2,400) units of HUMATE-P VWF:RCo Factor VIII Complex to the Park Ridge, Illinois location by December 5, 2023. No set-aside designation was applied to this award. The prime vendor contract held by DMS Pharmaceutical Group allows the Defense Logistics Agency to fulfill routine pharmaceutical needs at military hospitals through delivery orders for medical supplies such as atropine, intravenous saline, and midazolam hydrochloride priced on a firm fixed basis.
Generated 2/12/24, 9:20 AM